Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer center

BACKGROUND AND AIMS: The standard treatment of non-metastatic anal squamous cell carcinoma (ASCC) consists of chemotherapy with mitomycin (MMC) plus 5-fluorouracil (5FU) for 1–2 cycles concomitant with pelvic radiotherapy. Subsequent studies introduced cisplatin (CDDP) combined with 5FU, with unclea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Med Oncol
Principais autores: Rotundo, Maria Saveria, Zampino, Maria Giulia, Ravenda, Paola Simona, Bagnardi, Vincenzo, Peveri, Giulia, Dell’Acqua, Veronica, Surgo, Alessia, Trovato, Cristina, Bottiglieri, Luca, Bertani, Emilio, Petz, Wanda Luisa, Fumagalli Romario, Uberto, Fazio, Nicola
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7364808/
https://ncbi.nlm.nih.gov/pubmed/32728394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920940945
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados